Physician profile
Bassel B Ibrahim
NPI 1104863364
$1,192.15
in general payments reported to CMS, 2019-2025
12 companies · $200 in 2025
The $200 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $107 · 2020: $37.41 · 2021: $219 · 2022: $119 · 2023: $220 · 2024: $290 · 2025: $200.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $710.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $710.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $361.08 | 2019-2025 | Aveir |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $342.74 | 2022-2024 | Lifevest |
| Boston Scientific Corporation | $209.74 | 2024-2025 | General - Vascular Access, Rotapro, Synergy |
| Medtronic, INC. | $55.25 | 2025 | Corevalve Evolut R |
| Cardiovascular Systems INC. | $42.86 | 2021 | |
| Philips North America LLC | $38.12 | 2024 | (Cm9) Amb Mon & Diag Und |
| Cardiva Medical, INC. | $37.97 | 2019 | |
| Heartflow, INC. | $32.06 | 2022-2025 | |
| Vifor Pharma, INC. | $23.57 | 2022 | |
| Angiodynamics, INC. | $20.94 | 2019 | |
| Shockwave Medical, INC | $16.76 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Acist Medical Systems, INC. | $11.06 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bassel Ibrahim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.